News - Page 20 of 35 - MaRS Innovation

CBC News’ “The National” Features Granata Decision Systems

Amanda Lang interviews U of T prof and co-founder Craig Boutilier in segment on innovative start-ups and Canada’s future Following an appearance on the CBC’s “Lang and O’Leary Exchange” on November 28, MaRS Innovation UTEST company, Granata Decision Systems, appeared on CBC news “The National.” The segment included an interview with Amanda Lang. Watch Boutilier's interview with Lang for "The National" on CBC's website.  Founded by Craig Boutilier and Tyler Lu, Granata Decision Systems is one of the first six companies incubated through the UTEST program for early-stage technologies, ... Read more

Lang & O’Leary Exchange features Granata Decision Systems

UTEST company makes cameo through launch of OneEleven, Toronto's new data-driven accelerator for entrepreneurs CBC's Lang & O'Leary Exchange featured Granata Decision Systems, one of the first UTEST companies incubated through that program for early-stage technologies by MaRS Innovation and the University of Toronto, in their program on Wednesday, November 28, 2013. The data-driven company is one of eight to join the inaugural cohort for OneEleven, a new accelerator funded by OMERS Ventures, the Ontario Centres of Excellence, Ryerson University and other industry ... Read more

Stem Cell Therapeutics Merger, Technology Featured in Biotechnology Focus

In a November 25 article in Biotechnology Focus magazine, author Shawn Lawrence highlights Stem Cell Therapeutics and Trillium Therapeutics Inc. coming together in a reverse merger that creates more opportunities to advance early-stage research. The article profiles Dr. Aaron Schimmer and his discovery that Tigecycline is effective in killing leukemia cells and leukemia stem cells by shutting down their energy supply. Here's a quote from Lawrence's article: “Dr. Schimmer’s research is focused on drug repurposing – finding new indications for approved therapeutics. Focusing on established drugs ... Read more

MaRS Innovation Announces Collaboration with Johnson & Johnson Innovation

Collaboration will advance early-stage technologies and identify high-potential opportunities related to human health TORONTO, Nov. 25, 2013 - MaRS Innovation (MI), a Centre of Excellence for Commercialization and Research, today announced a new collaboration with Johnson & Johnson Innovation and its affiliate Janssen, Inc., in Canada to advance early-stage technologies related to human health in therapeutics, medical devices, and diagnostics. This announcement was covered by Biotechnology Focus and the Village Gamer blog. Through the collaboration, MaRS Innovation and technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will jointly ... Read more

Simple test could replace surgery to diagnose male infertility

Mount Sinai’s Lunenfeld-Tanenbaum Research Institute has developed a new test that could make a big difference to men facing infertility. A study published in a leading international journal, Science Translational Medicine, details the discovery of a key biomarker that can pinpoint the cause of infertility without the need for invasive surgery. This story was covered by BBC News, ABC News's "PM" with Mark Colvin, CTV News, CBC News, The Toronto Star, Globe and Mail, Ottawa Citizen and the Calgary Herald. About half a million ... Read more

CAMH, Assurex Health Partner to Bring Personalized Care to More Canadians

The Centre for Addiction and Mental Health and Assurex Health combine resources to bring personalized medicine in psychiatry, reducing the current trial-and-error approach TORONTO – The Centre for Addiction and Mental Health (CAMH), Canada’s leading hospital for mental health, and Assurex Health, a global leader in personalized medicine, have signed an agreement for a joint venture to bring the benefits of this treatment approach to more Canadians. The personalized approach helps to match the right medication at the right dose for each patient, based ... Read more

Flybits and City of Ottawa Launch Ottawa Nav

The City of Ottawa and Flybits Unveil New Traffic Management Tool That Provides Real-Time Traveler Information to Residents TORONTO, November 18, 2013 — The City of Ottawa and Flybits, an emerging Ryerson University start-up, announced today the release of a free mobile application called Ottawa Nav. This story has been covered by Yonge Street Media, The Ottawa Sun, TechVibes and Global TV. The app, using the Flybits platform, connects users to municipal services and infrastructure providing relevant real-time information from construction updates to collisions or speed limit ... Read more

MaRS Innovation launches streamlined funding program

Applications invited for MI’s Industry Access Program, which matches early-stage, high-potential technologies to partners and funding MaRS Innovation (MI) has launched a unique funding program to match researchers with industry partners while advancing early stage technologies: the MaRS Innovation Industry Access Program (MI-IAP). This program provides a simple mechanism to connect researchers with MI’s industry partners. The process and application form are intentionally brief to save researchers time and allow MI's partners to review a wide range of remarkable technologies within the Toronto academic ... Read more

WaveCheck crowdfunding campaign honours contriburing artists, sponsors and inventors

Reception at Sunnybrook Hospital recognizes WaveCheck's inventors, contributing artists and the three women featured in the campaign video The WaveCheck Indiegogo campaign continues to generate wide support from MaRS Innovation's community. To give back and show their appreciation, the campaign team hosted a reception at Sunnybrook Health Sciences Centre in the Louise Temerty Breast Cancer Centre on November 6, 2013. Present were several members of the Women's Art Association of Canada (WAAC) who donated 11 of the 15 artworks to the campaign. Also present was Dale Butterill, ... Read more

WaveCheck raises over $41,000 for breast cancer treatment monitoring in three weeks

Over 340 people worldwide have joined WaveCheck's Indiegogo crowdfunding campaign to fund a breakthrough clinical technique for breast cancer that promises to revolutionize the way chemotherapy is monitored. "Breast Cancer Awareness Month’s positivity makes it easy to overlook the fact that 60 to 70 per cent of chemotherapy treatments fail,” says Dr. Gregory Czarnota, chief of Radiation Oncology at Sunnybrook Health Sciences Centre and co-inventor of WaveCheck with Professor Michael C. Kolios of Ryerson University. “WaveCheck’s technology can tell people with breast ... Read more
Page 20 of 35« First...10...1819202122...30...Last »